Skip to content
Home/Companies/Healthcare/Destia (MMF V)

Destia (MMF V)

Healthcare·France·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns Destia (MMF V)?

Destia (MMF V) is a French Healthcare company, now owned by Siparex ETI, which acquired it in 2021 from Azulis Capital.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Azulis Capital
Investor
Azulis Capital
Azulis MMF V · 2015 · Buyout

Key facts

HQFrance
SectorHealthcare
Exit Type
Secondary
Buyer
Siparex ETI
Exit Year
2021

More from Azulis MMF V

Other portfolio companies in the same fund.

Talis Business School
Exited 2021
EducationFrance· 2020
to IDI
Eksae
Eksae
Active
TMTFrance· 2019
Frio - La Sommeliere
Active
ConsumerFrance· 2019
GROUPE FRIO
Groupe Frio
Active
ConsumerFrance· 2019
Groupe Hélios (GEC IDF)
Active
ConstructionFrance· 2019
Helios
Exited 2022
FintechFrance· 2019
to Groupe Batibig

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Destia (MMF V)?

Destia (MMF V) is now owned by Siparex ETI, which acquired it in 2021 from Azulis Capital.

When did Siparex ETI acquire Destia (MMF V)?

Siparex ETI acquired Destia (MMF V) in 2021, buying from Azulis Capital.

Who did Destia (MMF V) sell to?

Azulis Capital sold Destia (MMF V) to Siparex ETI in 2021 (Secondary).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue